Abstract
Astrocytes are principal mediators of homeostasis in the central nervous system (CNS). They supply neurons and oligodendrocytes with substrates for energy metabolism and clear the extracellular space of excess neurotransmitters. In neuroinflammation, astrocytes have classically been regarded as unimportant since their capacity to present antigen to T cells is limited and has been questioned in vivo. However, it is an evolving concept that autoimmunity in the CNS has a profound impact on astrocytes. In this review, we focus on the alterations in astrocyte functions that occur during an autoimmune attack of the CNS.
Similar content being viewed by others
References
Aasly J., Garseth M., Sonnewald U., Zwart J. A., White L. R., and Unsgard G. (1997) Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis. Acta Neurol. Scand. 95, 9–12.
Aloisi F., Ria F., and Adorini L. (2000) Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol. Today 21, 141–147.
Aloisi F., Care A., Borsellino G., et al. (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149, 2358–2366.
Anderson C. M. and Swanson R. A. (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 1–14.
Antony, J. M., van Marle G., Opii W., et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7, 1088–1095.
Asensio V. C., Maier J., Milner R., et al. (2001) Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J. Virol. 75, 7067–7077.
Barnett M. H. and Prineas J. W. (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55, 458–468.
Beal M. F. (1992) Role of excitotoxicity in human neurological disease. Curr. Opin. Neurobiol. 2, 657–662.
Benjamin A. M. and Quastel J. H. (1975) Metabolism of amino acids and ammonia in rat brain cortex slices in vitro: a possible role of ammonia in brain function. J. Neurochem. 25, 197–206.
Benveniste H., Drejer J., Schousboe A., and Diemer N. H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369–1374.
Bo L., Dawson T. M., Wesselingh S., et al. (1994) Induction of nitric oxides synthease in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778–786.
Bozzali M., Cercignani M., Sormani M. P., Comi G., and Filippi M. (2002) Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. Am. J. Neuroradiol. 23, 985–988.
Brambilla R., Bracchi-Ricard V., Hu W. H., et al. (2005) Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202, 145–156.
Brand-Schieber E., Werner P., Iacobas D. A., et al. (2005) Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamated white matter in an animal model of multiple sclerosis. J. Neurosci. Res. 80, 798–808.
Brück W. (2005) Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. J. Neurol. 252 (Suppl. 5), v10-v15.
Brück W. and Stadelmann C. (2003) Inflammation and degeneration in multiple sclerosis. Neurol. Sci. 24 (Suppl. 5), S265-S267.
Brune T., Fetzer S., Backus K. H., and Deitmer J. W. (1994) Evidence for electrogenic sodium-bicarbonate cotransport in cultured rat cerebellar astrocytes. Pflügers Arch. 429, 64–71.
Busa W. B. (1986) Mechanisms and consequences of pH-mediated cell regulation. Annu. Rev. Physiol. 48, 389–402.
Cendes F., Andermann F., Carpenter S., Zatorre R. J., and Cashman N. R. (1995) Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotixity in humans. Ann. Neurol. 37, 123–126.
Chaudhry F. A., Lehre K. P., van Lookeren C. M., Ottersen O. P., Danbolt N. C., and Storm-Mathisen J. (1995) Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15, 711–720.
Chih C. P., Lipton P., Robert E. L., Jr. (2001) Doactive cerebral neurons really use lactate rather than glucose?. Trends Neurosci. 24, 573–578.
Choi D. W. (1988) Glutamate neurotoxicity and diseases of the enrvous system. Neuron 1, 623–634.
Chung I. Y. and Benveniste E. N. (1990) Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144, 2999–3007.
Coles A. J., Cox A., Le Page E., et al. (2005) The window of therapeutic opportunity in multiple sclerosis Evidence from monoclonal antibody therapy. J. Neurol. 253, 98–108.
Croitoru-Lamoury J., Guillemin G. J., Boussin F. D., et al. (2003) Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 41, 354–370.
Davie C. A., Hawkins C. P., Barker G. J., et al. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49–58.
De Stefano N., Guidi L., Stromillo M. L., Bartolozzi M. L., and Federico A. (2003) Imaging neuronal and axonal degeneration in multiple sclerosis. Neurol. Sci. 24 (Suppl. 5), S283-S286.
De Stafano N., Narayanan S., Francis G. S., et al. (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch. Neurol. 58, 65–70.
Desplat-Jego S., Creidy R., Varriale S., et al. (2005) Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. Clin. Immunol. 117, 15–23.
Dirnagl U., Iadecola C., and Moskowitz M.A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391–397.
Erecinska M. and Silver I. A. (1990) Metabolism and role of glutamate in mammalian brain. Prog. Neurobiol. 35, 245–296.
Feinstein D. L., Galea E., Gavrilyuk V., et al. (2002) Peroxisome proliferatory-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51, 694–702.
Filippi M. and Rocca M. A. (2005) MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J. Neurol. 252(Suppl. 5), v16-v24.
Fox C. J., Hammerman P. S., and Thompson C. B. (2005) Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5, 844–852.
Fu I., Matthews P. M., De Stefano N., et al. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121, 103–113.
Garcia C. K., Goldstein J. L., Pathak R. K., Anderson R. G., and Brown M. S. (1994) Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell 76, 865–873.
Garcion E., Sindji L., Nataf S., Brachet P., Darcy F., and Montero-Menei C. N. (2003) Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol. (Berl.) 105, 438–448.
Gruetter R., Seaquist E. R., and Ugurbil K. (2001) A mathematical model of compartmentalized neurotransmitter metabolism in the human brain. Am. J. Physiol. Endocrinol. Metab. 281, E100-E112.
Halestrap A. P. and Meredith D. (2003) The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Eur. J. Physiol. 447, 619–628.
Hardin-Pouzet H., Krakowski M., Bourbonniere L., Didier-Bazes M., Tran E., and Owens T. (1997) Glutamatemetabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 20, 79–85.
Hynd M. R., Scott H. L., and Dodd P. R. (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease. Neurochem. Int. 45, 583–595.
Ikonomidou C. and Turski L. (1995) Excitotoxicity and neurodegenerative diseases. Curr. Opin. Neurol. 8, 487–497.
John G. R., Shankar S. L., Shafit-Zagardo B., et al. (2002) Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8, 1115–1121.
Kaila K. and Ransom B. R. (eds.) (1998) pH and brain function. New York: John Wiley & Sons Inc.
Kanai Y. and Hediger M. A. (2004) The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflügers Arch. 447, 469–479.
Kojima K., Berger T., Lassmann H., et al. (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by Tlymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J. Exp. Med. 180, 817–829.
Korn T., Magnus T., and Jung S. (2005a) Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J. 19, 1878–1880.
Korn T., Magnus T., and Jung S. (2005b) Interaction with antigen-specific T cells regulates expression of the lactate transporter MCT1 in primary rat astrocytes: Specific link between immunity and homeostasis. Glia 49, 73–83.
Lapidot A. and Gopher A. (1994) Cerebral metabolic compartmentation. Estimation of glucose flux via pyruvate carboxylase/pyruvate dehydrogenase by 13C NMR isotopomer analysis of D-[U-13C]glucose metabolites. J. Biol. Chem. 269, 27,198–27,208.
Lehre K. P. and Danbolt N. C. (1998) The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 18, 8751–8757.
Lennon V. A., Kryzer T. J, Pittock S. J., Verkman A. S., and Hinson S. R. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473–477.
Lennon V. A., Wingerchuk D. M., Kryzer T. J., et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106–2112.
Li J., Baud O., Vartanian T., Volpe J. J., and Rosenberg P. A. (2005) Peroxy nitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. USA 102, 9936–9941.
Lipton S. A. (1994) Ca2+, N-methyl-D-aspartate receptors, and AIDS-related neuronal injury. Int. Rev. Neurobiol. 36, 1–27.
Longuemare M. C. and Swanson R. A. (1997) Net glutamate release from astrocytes is not induced by extracellular potassium concentrations attainable in brain. J. Neurochem. 69, 879–882.
Lucchinetti, C. F., Brück W., Rodriguez M., and Lassmann H. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6, 259–274.
Luna-Medina R., Cortes-Canteli M., Alonso M., Santos A., Martinez A., and Perez-Castillo A. (2005) Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J. Biol. Chem. 280, 21,453–21,462.
Mattson M. P. Rychlik B., Chu C., and Christakos S. (1991a) Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 6, 41–51.
Mattson M. P., Rychlik B., You J. S., and Sisken J. E. (1991b) Sensitivity of cultured human embryonic cerebral cortical neurons to excitatory amino acid-induced calcium influx and neurotoxicity. Brain Res. 542, 97–106.
Matute C., Alberdi E., Ibarretxe G., and Sanchez-Gomez M. V. (2002) Excitotoxicity in glial cells. Eur. J. Pharmacol. 447, 239–246.
McDonald J. W., Althomsons S. P., Hyrc K. L., Cho D. W., and Goldberg M. P. (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4, 291–297.
Meeuwsen S., Persoon-Deen C., Bsibsi M., Ravid R., and van Noort J. M. (2003) Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243–253.
Mollace V. and Nistico G. (1995) Release of nitric oxide from astroglial cells: a key mechanism in neuroimmune disorders. Adv. Neuroimmunol. 5, 421–430.
Murphy P., Sharp A., Shin J., et al. (2002) Suppressive effects of ansamycins on induciblenitric oxidesynthase expression and the development of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 67, 461–470.
O’Connor E. R., Sontheimer H., and Ransom B. R. (1994) Rat hippocampal astrocytes exhibit electrogenic sodium-bicarbonate co-transport J. Neurophysiol. 72, 2580–2589.
Omari K. M., John G. R., Sealfon S. C., and Raine C. S. (2005) CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128, 1003–1015.
Pellerin L., Pellegri G., Bittar P. G., et al. (1998) Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev. Neurosci. 20, 291–299.
Pines G., Danbolt N. C., Bjoras M., et al. (1992) Cloning and expression of a rat brain L-glutamate transporter. Nature 360, 464–467.
Pitt D., Nagelmeier I. E., Wilson H. C., and Raine C. S. (2003) Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 61, 1113–1120.
Pitt D., Werner P., and Raine C. S. (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6, 67–70.
Pizzonia J. H., Ransom B. R., and Pappas C. A. (1996) Characterization of Na+/H+ exchange activity in cultured rat hippocampal astrocytes. J. Neurosci. Res. 44, 191–198.
Poole R. C. and Halestrap A. P. (1993) Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264, C761-C782.
Ransom B. R. and Fern R. (1997) Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation? Glia 21, 134–141.
Rothman S. M. and Olney J. W. (1995) Excitotoxicity and the NMDA receptor—still lethal after eight years. Trends Neurosci. 18, 57–58.
Rothstein J.D. (1995) Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 3, 348–359.
Rothstein J. D., Martin L., Levey A. I., et al. (1994) Localization of neuronal and glial glutamate transporters. Neuron 13, 713–725.
Rothstein J. D., Petel S., Regan M. R., et al.(2005) Betalactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 73–77.
Saas P., Boucraut J., Walker P. R., et al. (2000) TWEAK stimulation of astrocytes and the proinflammatory consequences. Glia 32, 102–107.
Sarchielli P., Greco L., Floridi A., Floridi A., and Gallai V. (2003) Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch. Neurol. 60, 1082–1088.
Schmitt A., Asan E., Puschel B., and Kugler P. (1997) Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: nonradioactive in situ hybridization and comparative immunocytochemistry. J. Neurosci. 17, 1–10.
Schurr A., Miller J. J., Payne R. S., and Rigor B. M. (1999) An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons. J. Neurosci. 19, 34–39.
Skias D. D., Kim D. K., Reder A. T., Antel J. P., Lancki D. W., and Fitch F. W. (1987) Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J. Immunol. 138, 3254–3258.
Smith K. J. and Lassmann H. (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1, 232–241.
Smith T., Groom A., Zhu B., and Turski L. (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat. Med. 6, 62–66.
Sospedra M. and Martin R. (2005) Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683–747.
Storck T., Schulte, S., Hofmann K., and Stoffel W. (1992) Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA 89, 10,955–10,959.
Strack A., Asensio V. C., Campbell I. L., Schluter D., and Deckert M. (2002) Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol. (Berl.) 103, 458–468.
Szymocha R., Akaoka H., Brisson C., et al. (2000a) Astrocytic alterations induced by HTLV type 1-infected T lymphocytes: a role for Tax-1 and tumor necrosis factor alpha. AIDS Res. Hum. Retroviruses 16, 1723–1729.
Szymocha R., Akaoka H., Dutuit M., et al. (2000b) Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J. Virol. 74, 6433–6441.
Takahashi J. L., Giuliani F., Power C., Imai Y., and Young V. W. (2003) Interleukin-1 beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann. Neurol. 53, 588–595.
Tanaka K., Watase, K., Manabe T., et al. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699–1702.
Trotti D., Rossi D., Gjesdal O., et al. (1996) Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271, 5976–5979.
Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981–989.
van Noort J. M., van Sechel A. C., Bajramovic J. J., et al. (1995) The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375, 798–801.
Watase K., Hashimoto K., Kano M., et al. (1998) Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Eur. J. Neurosci. 10, 976–988.
Wender R., Brown A. M., Fern R., Swanson, R. A., Farrell K., and Ransom B. R. (2000) Astrocytic glycogen influences axon function and survival during glucose deprivation in central whitematter. J. Neurosci. 20, 6804–6810.
Wiesinger H., Hamprecht B., and Dringen R. (1997) Metabolic pathways for glucose in astrocytes. Glia 21, 22–34.
Xu Y., Oz G., LaNoue K. F., et al. (2004) Whole-brain glutamate metabolism evaluated by steady-state kinetics using a double-isotope procedure: effects of gabapentin. J. Neurochem. 90, 1104–1116.
Yoshida H., Imaizumi T., Fujimoto K., et al. (2001) Synergistic stimulation, by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytes. Neurosci. Lett. 303, 132–136.
Zacco A., Togo J., Spence K., et al (2003) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci. 23, 11,104–11,111.
Zhou Z. H., Han Y., Wei T., et al. (2001) Regulation of monocyte chemoattractant protein (MCP)-1 transcription by interferon-gamma (IFN-gamma) in human astrocytoma cells: postinduction refractory state of the gene, governed by its upstream elements. FASEB J. 15, 383–392.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korn, T., Rao, M. & Magnus, T. Autoimmune modulation of astrocyte-mediated homeostasis. Neuromol Med 9, 1–15 (2007). https://doi.org/10.1385/NMM:9:1:1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/NMM:9:1:1